Antimicrobials in urogenital infections

被引:29
|
作者
Wagenlehner, Florian M. E. [1 ]
Wullt, Bjoern [2 ]
Perletti, Gianpaolo [3 ]
机构
[1] Univ Giessen, Dept Urol Pediat Urol & Androl, D-35385 Giessen, Germany
[2] Skane Univ Hosp, Dept Urol, Malmo, Sweden
[3] Univ Insubria Busto Arsizio, Lab Tossicol & Farmacol, Dipartimento Biol Strutturale & Funz, Varese, Italy
关键词
Urinary tract infection; Male genital infection; Antibiotic treatment; Antimicrobial substances; URINARY-TRACT-INFECTIONS; GRAM-NEGATIVE BACILLI; PHARMACOKINETIC PROPERTIES; ANTIBACTERIAL ACTIVITY; HOSPITALIZED-PATIENTS; SURVEILLANCE PROGRAM; TRIMETHOPRIM-SULFAMETHOXAZOLE; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; PROSTATIC FLUID;
D O I
10.1016/j.ijantimicag.2011.09.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Urinary tract infections (UTIs) and male genital infections are amongst the most prevalent infections. A prudent antibiotic policy therefore has a large impact on society. The clinical classification in uncomplicated cystitis, uncomplicated pyelonephritis, complicated UTI and genital infections is useful, also for the right choice of antibiotic treatment. In this regard pharmacokinetic and pharmacodynamic aspects have to be considered. Nowadays in uncomplicated cystitis antibiotics exclusively reserved for this indication are preferred, such as fosfomycin trometamol, nitrofurantoin and pivmecillinam, in order to reduce antibiotic pressure in this extremely frequent entity. In complicated UTI a broad bacterial spectrum has to be considered. Different antibiotic substances should be used for treatment, such as penicillins, with beta-lactamase inhibitors, cephalosporins or carbapenems, fluoroquinolones, aminoglycosides or cotrimoxazole, if tested susceptible. For genital infections the pharmacokinetic properties of the antibiotics should especially be considered, such as in prostatitis, where mainly fluoroquinolones and macrolides show sufficient pharmacokinetic parameters for treatment of bacterial infections. Furthermore in genital infections fastidious organisms, such as Chlamydia or Mycoplasma spp. have to be considered with respect to their antimicrobial susceptibility. (C) 2011 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [1] Urogenital tract infections in the elderly
    Weidner, W
    Hochreiter, W
    Liedl, B
    Ludwig, M
    Naber, KG
    Vahlensiek, W
    Wagenlehner, FME
    UROLOGE A, 2002, 41 (04): : 328 - 332
  • [2] Aetiopathology and pathogenesis of urogenital infections
    Schaeffer, AJ
    ANDROLOGIA, 1998, 30 : 3 - 6
  • [3] Urogenital infections - antimicrobial treatment
    Skerk, Visnja
    Markotic, Alemka
    MEDICINSKI GLASNIK, 2010, 7 (01) : 1 - 11
  • [4] Evaluation of microbiological diagnostics in urogenital infections in postmenopausal women
    Hunjak, Blazenka
    Persic, Zdenka
    MEDICINSKI GLASNIK, 2010, 7 (01) : 60 - 65
  • [5] Consensus on Treatment Recommendations for Urogenital Infections in Type 2 Diabetics
    Weissenbacher, E. R.
    Autenrieth, M.
    Bauer, H. W.
    Becker, A.
    Fuechtenbusch, M.
    Fuenfstueck, R.
    Hamann, A.
    Hummel, M.
    Hoyme, U. B.
    Jacob, S.
    Martius, J.
    Matthaei, S.
    Mendling, W.
    Mylonas, I.
    Pfeiffer, A.
    Schnell, O.
    Parhofer, K. G.
    DIABETES STOFFWECHSEL UND HERZ, 2012, 21 (03): : 179 - 184
  • [6] Clinical aspects of antimicrobial therapy used in patients with urogenital infections
    Vyalov, S. S.
    Vasina, T. A.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (12) : 97 - +
  • [7] Influence of urogenital infections on sperm functions
    Kohn, FM
    Erdmann, I
    Oeda, T
    El Mulla, KF
    Schiefer, HG
    Schill, WB
    ANDROLOGIA, 1998, 30 : 73 - 80
  • [8] Lactobacillus as a probiotic for preventing urogenital infections
    Andreu, A
    REVIEWS IN MEDICAL MICROBIOLOGY, 2004, 15 (01) : 1 - 6
  • [9] Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players
    Lee, Young R.
    McMahan, Danni
    McCall, Catherine
    Perry, Gregory K.
    DRUGS, 2015, 75 (18) : 2097 - 2117
  • [10] Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
    Sousa, Silvia A.
    Feliciano, Joana R.
    Pita, Tiago
    Soeiro, Catarina F.
    Mendes, Beatriz L.
    Alves, Luis G.
    Leitao, Jorge H.
    ANTIBIOTICS-BASEL, 2021, 10 (08):